Drug for treating diabetes mellitus

Abstract

The invention belongs to the technical field of Chinese patent medicine and in particular relates to a drug for treating diabetes mellitus. The drug is prepared by taking agrimonia pilosa, radix ophiopogonis, radix astragali seu hedysari, fructus schisandrae, radix notoginseng, herba dendrobii, radix puerariae, rhodiola and radix trichosanthis as raw materials according to a conventional powder preparation method. The drug is specifically prepared through the steps of uniformly mixing all the medicines in parts by weight, grinding into fine powder with the size of 120 meshes, and sub-packaging. Other dosage forms are processed through concentrating on the basis of the powder. Theoretical and clinical tests show that the traditional Chinese medicine preparation for adjusting glucose metabolism, provided by the invention, is safe, has no toxin and has a remarkable curative effect; the drug also has the advantages of simplicity in preparation, wide medicine sources, low cost and the like, and particularly has a very good effect on the initial stage of diabetes mellitus. The clinical efficiency is up to 100 percent and the curing rate reaches 70 percent.

Description

technical field [0001] The invention belongs to the technical field of Chinese patent medicines, in particular to a medicine for treating diabetes. Background technique [0002] Diabetes mellitus is a group of clinical syndromes mainly manifested by glucose metabolism disorders caused by genetic and environmental factors. Insulin deficiency and insulin action disorder alone or simultaneously cause metabolic disorders of carbohydrates, fats, proteins, water, and electrolytes. The main clinical feature is chronic hyperglycemia, and its complications may include diabetic ketoacidosis, hyperosmolarity, etc. Glycemic status and lactic acidosis. [0003] A large number of epidemiological data show that the number of diabetic patients is increasing rapidly all over the world, especially in developing countries including China. Diabetes has become a major clinical endocrine and metabolic disease. From 2007 to 2008, the diabetes epidemiological survey carried out by CDS in some are...

AI Technical Summary

Problems solved by technology

[0017] The purpose of the present invention is to solve many problems currently existing in the treatment of diabetes, through traditional Chinese medicine nourishing yin and moistening dryness, nourishing the liver and kidney, nourishing the heart and lungs, improving microcirculation, and regulating glucose metabolism, so as to solve the large fluctuations in blood sugar levels of diabetic patients and reduce the risk of Western medicine. Dosage and its side effects, prevention and treatment of its complications, repair of early impaired glucose tolerance, and provide a drug for the treatment of diabetes